Having built a robust portfolio, the fund manager has executed over 50 deals primarily in technology and healthcare sectors across Europe and North America. Their approach emphasizes a data-driven investment strategy, enabling the identification of high-growth opportunities at various stages, from early to growth equity. Notable exits have included several successful IPOs and acquisitions, underscoring a strong track record in value creation. With a commitment to thematic investing, they strategically align their portfolio with emerging market trends.